Group 1 - The company, Hengan International (01044), has completed the issuance of its third phase of ultra-short-term financing bonds amounting to RMB 2 billion, with an annual interest rate of 1.68% and a term of 183 days [1] - Following this issuance, there remains an approved but unissued debt financing tool amounting to RMB 800 million [1]

Group 1 - The core announcement is that Li Weiliang has resigned from his positions as Executive Director, Group Chief Financial Officer, and Company Secretary of the company to pursue other career opportunities, effective from April 1, 2026 [1] - Following Li Weiliang's resignation, the company has appointed Peng Yaozi as the new Company Secretary, Exchange Authorized Representative, and Section 16 Authorized Representative, also effective from April 1, 2026 [1]

執行董事及主席 施文博先生 執行董事及行政總裁 許清流先生 (于開曼群島註冊成立之有限公司) (股份代號:1044) 董事名單與其角色和職能 恒安國際集團有限公司董事會( ｢董事會｣ )成員載列如下： C 有關董事委員會的主席 M 有關董事委員會的委員 香港，2026 年 4 月 1 日 執行董事 許大座先生 施煌劍先生 許清池先生 許文默先生 獨立非執行董事 黃英琦女士 保羅希爾先生 何貴清先生 陳闖先生 董事會設立五個委員會，其他成員載列如下: | 董事 | 審核委員會 | 提名委員會 | 薪酬委員會 | 環境、社會 及管治委員 會 | 股份激勵 委員會 | | --- | --- | --- | --- | --- | --- | | 施文博先生 | | M | | | | | 許清流先生 | | M | M | C | | | 黃英琦女士 | C | M | M | | M | | 保羅希爾先生 | M | M | C | M | C | | 何貴清先生 | M | C | M | | M | | 陳闖先生 | M | M | M | M | M | 附注: ...

Group 1 - The company, Hengan International (01044), has completed the issuance of the third phase of ultra-short-term financing bonds amounting to RMB 2 billion, with an annual interest rate of 1.68% and a term of 183 days [1] - The results of the third phase of ultra-short-term financing will be published on the China Money website and the Shanghai Clearing House website [1] - Following this issuance, there remains an approved but unissued debt financing tool amounting to RMB 800 million [1]

Core Viewpoint - Heng An International (01044.HK) has successfully issued its third phase of ultra-short-term financing bonds amounting to RMB 2 billion with an annual interest rate of 1.68% and a term of 183 days [1] Group 1: Financing Details - The issuance of the third phase of ultra-short-term financing bonds will be published on the China Money website and the Shanghai Clearing House website [1] - Following the completion of this issuance, there remains an approved but unissued amount of RMB 800 million in debt financing tools [1] Group 2: Use of Proceeds - The proceeds from the issuance are intended to supplement the working capital of the company and its subsidiaries, as well as to repay company debts and some bank loans of domestic subsidiaries [1]

Core Viewpoint - Heng An International (01044) announced the resignation of Mr. Li Weiliang as Executive Director, Group Chief Financial Officer, and Company Secretary to pursue other career opportunities, effective April 1, 2026 [1] Group 1 - Mr. Li will also cease to serve as the company's authorized representative under the Hong Kong Stock Exchange Listing Rules Section 3.05 and as the authorized representative for receiving legal documents under Section 16 of the Companies Ordinance (Cap 622) from the same date [1] - The board has appointed Mr. Peng Yaochi as the new Company Secretary, authorized representative for the Stock Exchange, and authorized representative under Section 16, effective April 1, 2026 [1]

Core Viewpoint - Hengan International (01044.HK) announced the resignation of Li Weiliang as Executive Director, Group Chief Financial Officer, and Company Secretary to pursue other career development opportunities, effective from April 1, 2026 [1] Group 1 - Li Weiliang's resignation marks a significant leadership change within Hengan International [1] - The company is expected to seek a replacement for the key financial leadership role [1] - The timing of the resignation may impact the company's strategic direction and financial planning [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於開曼群島註冊成立的有限公司） （股份代號：1044） http://www.hengan.com http://www.irasia.com/listco/hk/hengan 網址： 本公司董事會（「董事會」）欣然宣佈，於二零二六年三月三十一日，本公司已完 成發行本金額為人民幣20億元的第三期超短期融資券（「第三期超短融」），其票面 利率定為每年1.68%及為期183日。發行第三期超短融的結果會於中國貨幣網 (www.chinamoney.com.cn)及上海清算所網站(www.shclearing.com.cn)刊登。緊隨 完成後，其餘已核准但未發行之債務融資工具金額為人民幣8億元。 發行第三期超短融所得項擬用作補充本公司及其附屬公司的營運資金以及償還本公 司債務及部分境內子公司的銀行貸款。 承董事會命 恒安國際集團有限公司 主席 施文博 香港，二零二六年三月三十一日 自願性公告 發行第三期超短期 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於開曼群島註冊成立的有限公司） （股份代號：1044） http://www.hengan.com http://www.irasia.com/listco/hk/hengan 網址： 執行董事與財務總監辭任事宜 公司秘書及授權代表之變動 執行董事、財務總監、公司秘書與獲授權代表辭任 董事會欣然宣佈，本公司已委任彭耀慈先生（「彭先生」）為公司秘書、聯交所授權代 表及第16部授權代表，自2026年4月1日起生效。 彭先生現年39歲，擁有逾17年審計、會計、財務報告及企業財務管理經驗，曾任職 於會計師事務所、香港上市發行人及國際企業。彭先生已於2026年3月加入本集團 並擔任財務及投資者關係總監一職。 彭先生在加入本公司之前，曾於2024年至2025年擔任CVC Asia Pacific Limited（其 控股公司為阿姆斯特丹泛歐交易所上市公司CVC Capital Partners plc）財務部副總 ...

Group 1 - The company reported a 3.9% year-on-year revenue growth in the second half of 2025, reaching 11 billion RMB, with a net profit increase of 31% to 1.1 billion RMB, outperforming both the bank and market expectations [1] - Excluding foreign exchange gains and losses, the estimated net profit growth for the second half of the year is 21% year-on-year [1] - The company's tissue and hygiene products business saw a sales increase of 8% year-on-year in the second half, accelerating from 3% growth in the first half [1] Group 2 - The management indicated that the tissue business volume grew by approximately 5% in 2025, benefiting from an improved high-end product mix and a 1 percentage point increase in average price [1] - Although sales volume in hygiene products declined, this was offset by an increase in average price [1] - The overall gross margin improved by 4 percentage points year-on-year and 3 percentage points quarter-on-quarter to 35.5%, aided by lower raw material prices and increased sales of high-margin products [1] Group 3 - The management expects continued intense competition in the hygiene products industry in 2026, planning to shift towards mid-to-high-end products to avoid price wars [1] - While wood pulp prices are expected to stabilize, management is concerned about supply chain uncertainties and raw material price increase risks due to conflicts in the Middle East [1] - Expansion into international markets and new product categories is anticipated to be the two main growth engines for sales over the next five years [1] Group 4 - UBS maintained a "Buy" rating for the company, raising profit forecasts for 2026 to 2028 by 4% to 9% based on strong performance in the second half of last year and better-than-expected high-end product performance [2] - The target price was increased from 32.5 HKD to 34.9 HKD, based on discounted cash flow valuation, equivalent to a projected price-to-earnings ratio of 14 times for 2026 [2] - The current price corresponds to a projected price-to-earnings ratio of 11 times for 2026, with an expected dividend yield of 6% [2]